Table 6 Example of drugs and nucleic acids which were delivered by carbon nanotubes
From: Carbon nanotubes: properties, synthesis, purification, and medical applications
Drug/nucleic acid | CNT type | Cell or tissue | Properties | Reference |
---|---|---|---|---|
Taxoid | SWNTs | Leukemia | High potency toward specific cancer cell lines | [116] |
Doxorubicin | SWNTs | Colon cancer | Efficiently taken up by cancer cells, then translocates to the nucleus while the nanotubes remain in the cytoplasm | |
Cisplatin | SWNTs | Squamous carcinoma | Rapid regression of tumor growth | [117] |
Cisplatin | SWNTs | Nasopharyngeal epidermoid carcinoma, etc. | High and specific binding to the folate receptor (FR) for the SWNT-1 conjugate | [118] |
Doxorubicin | SWNTs | Breast cancer Glioblastoma | Show that large surface areas on single-walled carbon nanotubes (SWNTs) | [119] |
Doxorubicin | SWNTs | Cervical carcinoma | Increase nuclear DNA damage and inhibit the cell proliferation | [115] |
Radionuclide | SWNTs | Burkitt lymphoma | The selective targeting of tumor in vitro and in vivo | [120] |
Paclitaxel | SWNTs | Breast cancer | High treatment efficacy, minimum side effects | [121] |
siRNA | SWNTs | Tumor cells both in vitro and in vivo mouse models | Increase suppression of tumor growth | [122] |
Toxic siRNA sequence (siTOX) | Functionalized MWNTs | Human lung xenograft model | Significant tumor growth inhibition | [123] |
siRNA | SWNT | Human neuroblastoma | Enhance the efficiency of siRNA-mediated gastrin-releasing peptide receptor (GRP-R) gene silencing | [124] |
SOCS1 siRNA | sWNT | Dendritic cells (DCs) | Reduced SOCS1 expression and retarded the growth of established B16 tumor in mice | [125] |